Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy
Clinical trial NCT02317393 · COMPLETED
Trial details
- NCT number
- NCT02317393
- Sponsor
- Centre Francois Baclesse
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2020-03-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.